Pillstats
Rx only · Capsule · Oral

Dabigatran Etexilate

Brands: Dabigatran · Dabigatran Etexilate Mesylate

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US33 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers13 labelers
Packages50
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 28 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.331$0.662$0.993$1.32Dec 2025Apr 2026Jul 2026
$0.888
Latest avg · Jul 8, 2026
-23%
Since Dec 17, 2025
13
Active US suppliers
40%
Top-2 supplier share*

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown14SUPPLYING
Novadoz Pharmaceuticals LLCunknown6SUPPLYING
Aurobindo Pharma Limitedunknown6SUPPLYING
Camber Pharmaceuticals, Inc.unknown6SUPPLYING
Apotex Corp.unknown3SUPPLYING
Dr.Reddy's laboratories Limitedunknown3SUPPLYING
American Health Packagingunknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
AvKAREunknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING
XLCare Pharmaceuticals Inc.unknown2SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
AvPAKunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.